Niki BioSolutions, Inc. (NIKI) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Niki BioSolutions, Inc. (NIKI) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $561,915, listed on NASDAQ, employing roughly 1 people, carrying a beta of 0.17 to the broader market. Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. Led by Chung Yuen Huen, public since 2026-07-20.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for NIKI as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →